| Autor: |
Albrecht, Valerie S., Zervos, Marcus J., Kaye, Keith S., Tosh, Pritish K., Arshad, Samia, Hayakawa, Kayoko, Kallen, Alexander J., McDougal, Linda K., Limbago, Brandi M., Guh, Alice Y. |
| Zdroj: |
Infection Control & Hospital Epidemiology; December 2014, Vol. 35 Issue: 12 p1531-1534, 4p |
| Abstrakt: |
We assessed for vancomycin-resistant Staphylococcus aureus(VRSA) precursor organisms in southeastern Michigan, an area known to have VRSA. The prevalence was 2.5% (pSK41-positive methicillin-resistant S. aureus, 2009–2011) and 1.5% (Inc18-positive vancomycin-resistant Enterococcus, 2006–2013); Inc18 prevalence significantly decreased after 2009 (3.7% to 0.82%). Risk factors for pSK41 included intravenous vancomycin exposure.Infect Control Hosp Epidemiol2014;35(12):1531–1534 |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
